UNSPSC 50501521: Diosmin

This classification denotes a bioflavonoid with the molecular formula C28H32O15, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 7QM776WJ5N, chemically known as 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)- but more generally known as diosmin, which bears U.S. National Institutes of Health Compound Identifier 5281613.

UNSPSC 50501521 Diosmin is a Commodity code for a bioflavonoid pharmaceutical ingredient used in state and local health-system procurement, particularly for venous insufficiency and lymphatic-disorder treatments. State and local governments purchase diosmin as a finished pharmaceutical product or as a raw ingredient for compounding by health departments, hospital systems, correctional facilities, and public clinics. The code encompasses both branded and generic formulations, typically in oral tablet or capsule form, and covers procurement by state Medicaid programs, county health authorities, and municipal hospital networks.

The source provided contains no recent state or local contract opportunities posted under this code. Without posted opportunities in the most-recent-opportunities block, no geographic concentration, issuing-body mix, or representative solicitation details can be drawn.